Why Molina Healthcare’s Medicaid redetermination outreach tool matters for patients
Molina Healthcare's Medicaid Redetermination Outreach solution helps millions of US members retain their health coverage by guiding them through the renewal process. The service uses multi-channel communication like texts, calls, and app alerts to nudge members to renew their eligibility. While effective, the system faces limitations such as outdated contact data or overburdened state agencies, and its success is crucial for Molina Healthcare's revenue stability.
Molina Healthcare Inc. stock underperforms Wednesday when compared to competitors
Molina Healthcare Inc. (MOH) shares dropped 2.34% on Wednesday, closing at $195.53. This underperformance occurred during a generally poor trading session where the S&P 500 Index and Dow Jones Industrial Average also saw declines. It marked the stock's second consecutive day of losses.
Molina Healthcare of Michigan and The MolinaCares Accord Donate $275,000 to Genesee County Habitat for Humanity
Molina Healthcare of Michigan and The MolinaCares Accord have donated $275,000 to Genesee County Habitat for Humanity. This grant will fund the organization's home repair program, assisting low-to-moderate income homeowners with essential repairs and improving overall community health and stability. The initiative aligns with Genesee County's 2026 Action Plan, emphasizing increased homeownership and community development.
Humana's Illinois Medicaid Win: A Strategic Bet on Whole-Person Care
Humana has secured a significant statewide contract to manage care for Illinois's Medicaid population, marking a strategic expansion into the government-sponsored health sector. This win, valued potentially up to $431 billion, positions Humana to serve over 2 million residents across all 102 counties starting in January 2027. The contract emphasizes "whole-person care," requiring Humana to address social and environmental factors affecting health outcomes, a move crucial for diversifying its portfolio amid a turbulent Medicaid environment.
Why Molina Healthcare’s MyChoice Rewards card matters for everyday members
Molina Healthcare's MyChoice Rewards card allows Medicaid and Medicare members to earn monetary rewards for completing health-related activities, which can then be spent on essential items like over-the-counter medicines, personal care products, and healthy groceries. This program aims to promote preventive care and healthy habits by providing tangible benefits, while also aligning with Molina's strategy to meet state Medicaid agencies' demands for better quality scores. The card operates like a restricted prepaid card, ensuring funds are used for health and basic needs, though benefits and eligible items can vary by state and plan.
Molina Healthcare Inc (MOH) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Molina Healthcare Inc.'s (MOH) dividend and stock split history, noting that no dividend data or stock split data is available. It includes current stock performance metrics such as market cap and P/E ratio, along with its current share price. The article indicates that no dividends have been distributed over the past five years.
|‘Big Short’ Investor Michael Burry Sticks With MOH Bet At $154 — Plans To Add More Shares
|Michael Burry, known from "The Big Short," plans to increase his stake in Molina Healthcare (MOH) at $154, citing "rock bottom low" investor expectations despite strong Q1 results. Burry views the insurer's medical care ratio beat as stopping the "bleeding narrative" around rising healthcare costs and believes the company can achieve $20+ EPS within a few years, potentially reaching $25. He compares Molina to Warren Buffett's early GEICO investment, emphasizing its long-term potential.
Monthly premium relief, Molina Healthcare Marketplace plans sharpen their pitch
Molina Healthcare is promoting its individual Marketplace health plans for the 2025 plan year as a cost-effective option for individuals and families who purchase their own insurance. The plans emphasize $0 telehealth and preventive care, alongside federal premium subsidies. Molina's strategy focuses on narrow, community-based provider networks to offer competitive pricing, especially in states like California, Texas, and Washington.
Vanguard VBR vs State Street SLYV: Which Small-Cap Value ETF Is the Better Buy?
This article compares two small-cap value ETFs: Vanguard Small-Cap Value ETF (VBR) and State Street SPDR S&P 600 Small Cap Value ETF (SLYV). While SLYV has shown higher recent returns, VBR is recommended for long-term investors due to its lower expense ratio, broader diversification, and superior long-term performance. The comparison highlights their investment strategies, costs, and performance statistics across various timeframes.
Top Medicare Advantage plans deny up to 80% of rehab requests
A new OIG report reveals that the three largest Medicare Advantage insurers—CVS Health, Humana, and UnitedHealth Group—deny inpatient rehab requests at significantly higher rates than their peers, with some denial rates reaching up to 80%. These high denial rates, particularly for long-term care hospitals and inpatient rehabilitation facilities, raise concerns about millions of people not receiving necessary care. The OIG suggests that the use of outside contractors and the lack of detailed prior authorization data contribute to these disparities, recommending that CMS collect more granular data and assess the reasons behind variable denial rates.
Is Molina Healthcare (MOH) a Great Value Stock Right Now?
Molina Healthcare (MOH) is highlighted as a strong value stock due to its favorable Zacks Rank #2 (Buy) and "A" grade for Value. The company exhibits attractive valuation metrics, including a Forward P/E of 9.08, a P/B ratio of 2.06, and a P/S ratio of 0.23, all of which are lower than its industry averages. These indicators suggest that MOH may be undervalued by the market.
Expanded virtual care, Molina Healthcare MyCare powered by Teladoc targets Medicaid members
Molina Healthcare has launched MyCare powered by Teladoc to provide virtual primary and urgent care to its Medicaid and Medicare members. This service offers 24/7 access to doctors via phone or video for non-emergency issues, aiming to reduce wait times and improve access for underserved populations. The program integrates with Molina's existing digital platforms and utilizes Teladoc's clinician network to manage common conditions, send prescriptions, and support care coordination, ultimately targeting better health outcomes and cost control.
Mizuho Raises its Price Target on Molina Healthcare (MOH)
Mizuho raised its price target on Molina Healthcare (NYSE:MOH) to $215 from $200 and maintained an Outperform rating, noting a "more stable and predictable" policy environment in the managed care sector. JPMorgan also increased its price target to $191 from $169 with a Neutral rating. Molina Healthcare, which provides managed healthcare services, is projecting strong premium growth to approximately $48 billion by 2027 and $64 billion by 2029.
MOH Wins Illinois Medicaid Contract, Reinforcing Long-Term Stability
Molina Healthcare, Inc. (MOH) secured a HealthChoice Illinois Medicaid Managed Care contract, set to begin in January 2027, with potential extensions for over a decade. This contract ensures Molina's participation in a significant Medicaid market, protecting its membership and revenue amidst industry enrollment challenges, and reinforcing the long-term stability and growth prospects of its core Medicaid business.
Molina Healthcare Inc. stock outperforms competitors on strong trading day
Molina Healthcare Inc. (MOH) stock rose 3.66% to $200.28 on Friday, outperforming its competitors and the broader market. This advance ended a two-day losing streak for the company's shares. The S&P 500 Index and the Dow Jones Industrial Average also saw gains on the strong trading day.
Mountain Lake Acquisition Corp Completes Business Combination With Avalanche Treasury Corporation, Shares Begin Trading on Nasdaq
Mountain Lake Acquisition Corp (MLAC) has successfully completed its business combination with Avalanche Treasury Corporation (AVAT), with AVAT's Class A common stock beginning to trade on Nasdaq under the ticker symbol "AVAT" as of June 11, 2026. This merger was approved by MLAC's shareholders on June 4, 2026, and allows investors exposure to the Avalanche blockchain ecosystem. Legal and financial advisors for the transaction included Ellenoff Grossman & Schole LLP, Skadden, Arps, Slate, Meagher & Flom LLP, and BTIG, LLC.
Molina Healthcare Inc. stock underperforms Thursday when compared to competitors
Molina Healthcare Inc. (MOH) shares declined by 2.37% on Thursday, closing at $193.20. This underperformance occurred despite a positive trading session for the broader market, with the S&P 500 Index and Dow Jones Industrial Average both seeing gains. This marks the second consecutive day of losses for the stock.
Humana Closes the Kindred Chapter With $900 Million Gentiva Exit
Humana Inc. has agreed to sell its remaining minority stake in Gentiva for approximately $900 million, completing its strategy to exit businesses outside its core health insurance and home-health strategy. This move simplifies Humana's portfolio and focuses management on areas with stronger long-term strategic value, with the proceeds used for general corporate purposes. The divestiture is not expected to materially impact Humana's 2026 earnings, despite Gentiva Hospice generating $2.1 billion in revenues in 2025.
Cantor Fitzgerald reiterates UnitedHealth stock Overweight rating
Cantor Fitzgerald has reiterated its Overweight rating on UnitedHealth Group (NYSE:UNH) with a $440.00 price target, identifying upcoming Medicaid contract decisions as crucial catalysts for the health insurer. Key contracts in Texas and Georgia involving significant numbers of enrollees and substantial financial values are reaching resolutions, with UnitedHealth being a major participant. This analysis also highlighted CVS Health's performance and undervaluation according to InvestingPro, alongside its recent updates to commercial formularies which include adding Zepbound.
Cantor Fitzgerald reiterates CVS Health stock Overweight rating
Cantor Fitzgerald reaffirmed its Overweight rating on CVS Health (NYSE:CVS) with a $100 price target, noting the stock's significant gains over the past year. The firm estimates a contract value of $3.6 billion in revenue for CVS Health, contributing $0.04 to earnings per share. This positive outlook is based on their analysis that CVS appears undervalued and is well-positioned in ongoing managed care contracts.
Molina Healthcare Wins Illinois Medicaid Contract
Molina Healthcare of Illinois, a subsidiary of Molina Healthcare, Inc., has been awarded a HealthChoice Illinois Medicaid Managed Care program contract by the Illinois Department of Healthcare and Family Services. The contract is set to begin on January 1, 2027, and will cover approximately 3.1 million Medicaid beneficiaries in Illinois. The agreement has an initial duration of four-and-a-half years, with an option for an additional five-and-a-half-year extension.
Cantor Fitzgerald reiterates Humana stock rating on Illinois Medicaid win By Investing.com
Cantor Fitzgerald has reiterated an Overweight rating and a $264.00 price target for Humana Inc. after the company secured a new Illinois Medicaid contract, adding it as a new entrant alongside incumbents like Centene and CVS Health. This $30 billion contract, covering approximately 3.1 million members, is expected to begin in January 2027 and reflects Humana's continued expansion in healthcare services. Despite the analyst's price target being lower than Humana's current trading price of $364.46, the company's stock has shown strong momentum with a 43% year-to-date gain and is trading near its 52-week high, while an InvestingPro analysis suggests it remains undervalued.
BI Asset Management Fondsmaeglerselskab A S Sells 12,368 Shares of Molina Healthcare, Inc $MOH
BI Asset Management Fondsmaeglerselskab A S reduced its stake in Molina Healthcare, Inc (NYSE:MOH) by 84.9% in the fourth quarter, selling 12,368 shares and retaining 2,194 shares valued at approximately $381,000. Despite this and other institutional moves, institutions still own 98.5% of the company's stock. Analysts currently hold a consensus "Hold" rating for Molina Healthcare with an average price target of $182.73, even after the company surpassed its EPS estimates in its recent quarterly report.
Molina Healthcare wins Illinois Medicaid contract for 2027
Molina Healthcare's Illinois subsidiary has been awarded a HealthChoice Illinois Medicaid Managed Care program contract, set to begin on January 1, 2027. This contract will cover approximately 3.1 million Medicaid beneficiaries for an initial four-and-a-half years, with an option for an additional five-and-a-half years. The company's financial health is rated "GOOD" by InvestingPro, and recent analyst updates show positive revisions to price targets due to efficiency goals and an improved cost outlook.
Molina Says Its Warnings Doom Suit Over Guidance Cuts
Molina Healthcare and two executives are seeking to dismiss a shareholder lawsuit alleging they misled investors about medical costs and internal controls. The company argues that its prior warnings about potential risks should negate the claims of the suit. The case was filed in a California federal court.
Molina Healthcare Inc. stock underperforms Wednesday when compared to competitors
Molina Healthcare Inc. (MOH) stock decreased by 2.55% on Wednesday, closing at $197.89. This underperformance occurred during a generally poor trading session where the S&P 500 Index and Dow Jones Industrial Average also fell. The stock's decline ended a two-day winning streak.
Molina Healthcare Wins Illinois Medicaid Contract
Molina Healthcare's Illinois subsidiary has been selected by the Illinois Department of Healthcare and Family Services to receive a HealthChoice Illinois Medicaid Managed Care program contract. The contract is expected to begin on January 1, 2027, and will have an initial duration of four-and-a-half years, with potential for extension. Molina Healthcare of Illinois will be one of six health plans providing coverage to approximately 3.1 million Medicaid beneficiaries in the state.
Molina Healthcare wins Illinois Medicaid contract for 2027 By Investing.com
Molina Healthcare's Illinois subsidiary has been awarded a HealthChoice Illinois Medicaid Managed Care program contract, set to begin January 1, 2027, for an initial four-and-a-half-year term. The company, a Fortune 500 managed healthcare provider, will serve approximately 3.1 million Medicaid beneficiaries. Despite potential risks like protests or delays, analysts have revised price targets upward for Molina Healthcare, citing improved medical cost outlooks and efficiency goals.
MOLINA HEALTHCARE, INC. Reports Material Event
Molina Healthcare, Inc. (NYSE: MOH) announced that its Illinois subsidiary is intended to be awarded a HealthChoice Illinois Medicaid Managed Care program contract. The contract is expected to begin on January 1, 2027, for an initial four-and-a-half years, with an option for an additional five-and-a-half years. This positions Molina Healthcare of Illinois as one of six health plans serving approximately 3.1 million Medicaid beneficiaries in the state, though the announcement is subject to various risks, including potential protests or delays.
Molina Healthcare Wins Illinois Medicaid Contract
Molina Healthcare, Inc. announced that its Illinois subsidiary, Molina Healthcare of Illinois, has been awarded a HealthChoice Illinois Medicaid Managed Care program contract by the Illinois Department of Healthcare and Family Services. This contract is expected to begin on January 1, 2027, and will last for four-and-a-half years, with potential extensions. Molina will be one of six health plans serving approximately 3.1 million Medicaid beneficiaries in Illinois.
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Jazz Pharmaceuticals (JAZZ) and Humana (HUM)
This article summarizes recent analyst ratings for three healthcare companies: Verastem (VSTM), Jazz Pharmaceuticals (JAZZ), and Humana (HUM). Mizuho Securities reiterated a Buy rating on Verastem with a $14 price target, while Bernstein maintained a Hold rating on Jazz Pharmaceuticals with a $229 price target. For Humana, Bernstein maintained a Buy rating with a target of $425, though the analyst consensus for Humana is currently Hold.
The MolinaCares Accord Presents $95,000 to March of Dimes in Support of Connecting Families to Doulas
The MolinaCares Accord, in partnership with Molina Healthcare of Illinois, has granted $95,000 to the March of Dimes' Doula-Hospital Integration Program (D-HIP) in Chicago. This initiative aims to connect expectant mothers at Advocate Trinity Hospital with community-based doulas, providing continuous and culturally responsive support before, during, and after birth. The program seeks to address significant disparities in maternal and infant health outcomes, particularly among Black women in Illinois who face higher pregnancy-related mortality rates.
Norges Bank Buys Shares of 632,509 Molina Healthcare, Inc $MOH
Norges Bank acquired a new stake of 632,509 shares in Molina Healthcare, Inc. (NYSE:MOH) during the fourth quarter, valued at approximately $109.8 million, representing about 1.17% of the company. The stock is trading above its 50-day and 200-day moving averages, with a market capitalization of $10.02 billion. Despite beating EPS estimates, Molina's revenue was slightly below forecasts, and analysts currently maintain a consensus "Hold" rating with a $179.93 price target.
ING Groep NV Increases Stake in Molina Healthcare, Inc $MOH
ING Groep NV significantly increased its stake in Molina Healthcare, Inc. by 575.7% in the fourth quarter, now owning 47,343 shares valued at approximately $8.2 million. Molina Healthcare reported strong quarterly earnings, beating EPS estimates, though revenue was slightly below expectations and down year-over-year. Despite recent insider share sales, analysts generally rate the stock as "Hold" with a consensus target price of $179.93.
Morgan Stanley Remains Bullish on UnitedHealth (UNH) Amid Sector Recovery
Morgan Stanley and Mizuho have both reiterated positive outlooks on UnitedHealth (UNH), raising price targets. Morgan Stanley cited softer utilization trends and the potential for AI to drive revenue growth and cost management, projecting significant EPS upside for the sector. Mizuho pointed to a more stable and predictable policy environment in managed care, which should allow investors to focus on company fundamentals.
Molina Healthcare Inc. stock outperforms competitors on strong trading day
Molina Healthcare Inc. (MOH) shares rallied 3.96% to $198.41 on Monday, outperforming the broader market which saw mixed results with the S&P 500 Index rising and the Dow Jones Industrial Average falling. The company's stock closed 36.31% below its 52-week high. This performance occurred during an overall mixed trading session for the stock market.
Molina Healthcare Inc (MOH) Stock Analysis: Examining the Performance and Outlook Amidst Market Fluctuations
Molina Healthcare Inc (MOH), a leading player in the healthcare plans industry, focuses on providing managed healthcare services to low-income families through Medicaid and Medicare. The company's stock is currently priced at $190.86, within a volatile 52-week range, and analysts have a predominantly neutral sentiment with an average target price of $187.94. Despite revenue contraction, Molina exhibits profitability with an EPS of 3.72 and strong free cash flow, indicating a reinvestment strategy geared towards growth and stability.
Fiera Capital Corp Purchases 73,131 Shares of Molina Healthcare, Inc $MOH
Fiera Capital Corp significantly increased its stake in Molina Healthcare, Inc (NYSE:MOH) during the fourth quarter, purchasing an additional 73,131 shares to bring its total holding to 314,712 shares valued at approximately $54.6 million. Despite Molina Healthcare reporting stronger-than-expected earnings of $2.35 EPS, exceeding the $1.57 estimate, its revenue of $10.80 billion slightly missed forecasts and decreased by 3.1% year-over-year. Analysts currently hold a cautious "Hold" consensus rating with an average price target of $179.93, although some, like Bank of America, have upgraded the stock to "buy."
Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Investors to Connect
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Molina Healthcare, Inc. (MOH) for alleged corporate wrongdoing. The firm encourages investors who purchased Molina securities before February 5, 2025, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, aiming to recover investor capital and ensure corporate accountability.
Free cash flow per share of Molina Healthcare, Inc. – XETR:MHG
The article serves as a financial data page for Molina Healthcare, Inc. (XETR:MHG) on TradingView, focusing specifically on its free cash flow per share. It provides a placeholder for the period, value, and change metrics for this financial indicator. The page also lists market data providers and copyright information.
A Look At Molina Healthcare’s (MOH) Valuation After A Recent Share Price Rebound
Molina Healthcare (MOH) has experienced a recent share price rebound, with a 9.9% 7-day and 30.7% 90-day gain, despite a 35.7% decline over the past year. Analyst narratives suggest the stock is overvalued at $190.86, with a fair value of $149.76, primarily due to modest revenue growth and thin margins. However, Simply Wall St's discounted cash flow model presents a contrasting view, valuing the stock at $625.08 per share, indicating a significant discount.
Total debt per share of Molina Healthcare, Inc. – XETR:MHG
The article provides financial information for Molina Healthcare, Inc. (XETR:MHG), specifically focusing on its "Total debt per share." It indicates that market data is provided by ICE Data Services and reference data by FactSet.
Revenue per share of Molina Healthcare, Inc. – XETR:MHG
This article provides financial information for Molina Healthcare, Inc. (XETR:MHG), specifically focusing on its revenue per share. It indicates that the market was closed at the time of publication and lists the company's stock information on Deutsche Borse Xetra.
ETFs Investing in Molina Healthcare, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Molina Healthcare, Inc. The ETFs are sorted by market value and provide details such as issuer, management style, expense ratio, assets under management (AUM), and 3-year total return. This information aims to help investors identify different avenues for investing in Molina Healthcare, Inc. indirectly through diversified funds.
Centene Corporation Trade Ideas — XETR:QEN
This article compiles several trade ideas and analyses for Centene Corporation (XETR:QEN, NYSE:CNC) from various contributors. It includes bullish, base, and bearish case valuations through 2029, technical analyses, and reactions to market events like potential Obamacare subsidy extensions and earnings reports. The overarching theme is diverse perspectives on Centene's stock performance amidst healthcare industry challenges and opportunities.
Molina Healthcare Inc. stock underperforms Friday when compared to competitors
Molina Healthcare Inc. (MOH) stock experienced a decline of 1.01% on Friday, closing at $190.86. This underperformance occurred during a generally poor trading session for the stock market, as both the S&P 500 Index and Dow Jones Industrial Average also fell. The stock's fall ended a two-day winning streak.
Should Invesco S&P SmallCap 600 Revenue ETF (RWJ) Be on Your Investing Radar?
The Invesco S&P SmallCap 600 Revenue ETF (RWJ) provides broad exposure to the US Small Cap Blend market, with over $1.89 billion in assets. It has an expense ratio of 0.39% and has shown strong year-to-date performance with a 17.32% gain, and a one-year gain of 38.82%. RWJ holds a Zacks ETF Rank of 3 (Hold) and is suggested for investors seeking exposure to the Small Cap Blend segment, with alternatives like IWM and IJR also mentioned.
The Sound of a Second Chance: DaVita Patients Celebrate Receiving Their Kidney Transplant
This article highlights the profound journey of DaVita patients receiving kidney transplants and the crucial role of multidisciplinary care teams in supporting them. It emphasizes the comprehensive support provided by DaVita teammates, from navigating treatment options and insurance to offering emotional encouragement. The piece also promotes DaVita's investment in kidney transplantation and their presence at the 2026 Transplant Games.
Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. (MOH) securities. The investigation focuses on whether Molina and its officers engaged in corporate wrongdoing, particularly for investors who bought shares before February 5, 2025, and still hold them. The firm encourages affected stockholders to contact them to assist with the investigation, which is conducted on a contingency fee basis.
Molina Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains
Molina Healthcare Inc. (MOH) shares rose 4.32% on Thursday, closing at $192.81, despite underperforming compared to broader market indices like the S&P 500 and Dow Jones Industrial Average, which also saw gains. This marked the stock's second consecutive day of increases.
